Delivery Order SPE2DB22D3301-SPE2DB25FY9HF
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,381.44 to AmerisourceBergen Drug Corp for the supply of Cefepime-Dextrose 2 GM/50 MLS, a broad-spectrum antibiotic commonly used in acute care settings. The contract was awarded on September 8, 2025, with an ultimate completion date of September 9, 2025, and represents a firm fixed price delivery order with no set-aside designation. Performance will be executed from AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $3,318.31 to AmerisourceBergen Drug Corp for the supply of Cefepime-Dextrose 2 GM/50 MLS, an antibiotic pharmaceutical product. This non-set-aside, firm fixed price delivery order was awarded on July 27, 2025, with a completion date of July 28, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Cefepime-Dextrose 2 GM/50 MLS, a pharmaceutical product valued at $20,952.85. This firm fixed-price delivery order, which has an ultimate completion date of September 12, 2025, represents a competitive award with no set-aside designation. The work will be performed in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office. This delivery order...
- The Defense Logistics Agency awarded a $2,620.75 delivery order to AmerisourceBergen Drug Corp for Cefepime-Dextrose 2 gm/50 mls, an antibiotic solution used in military and federal healthcare settings. This firm fixed price contract, awarded on August 26, 2025, with an ultimate completion date of August 27, 2025, represents a competitive award with no set-aside designation. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order valued at $7,354.05 to AmerisourceBergen Drug Corp for the supply of Cefepime-Dextrose 2 GM/50 MLS, an intravenous antibiotic formulation used for bacterial infections in military and federal healthcare settings. The contract, executed on September 3, 2025, with an ultimate completion date of September 4, 2025, employs firm fixed pricing under a non-competitive, non-set-aside delivery order arrangement. Performance will occur at the...
- The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order valued at $2,876.94 to Amerisourcebergen Drug Corp's Corporate Office division to provide 4,564,478,187 units of Cefepime-Dextrose 2 gm/50 mL. This order falls under Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a total potential value of up to $999,999,999.00 and runs through December 31, 2025. The IDC enables the DLA to efficiently procure a comprehensive...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,287.99 firm fixed-price delivery order is for the supply of Cefepime-Dextrose 2 GM/50 MLS, a pharmaceutical product. The contract has an ultimate completion date of January 19, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on September 4, 2025, by the Defense Logistics Agency (DLA) for the supply of Cefepime-Dextrose 2 GM/50 MLS. This competitively awarded, firm fixed-price delivery order is valued at $12,695.91 and carries an ultimate completion date of September 5, 2025. The product will be delivered to the Conshohocken, PA location. As a child contract under a larger vehicle,...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $14,903.68 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The contract is for the delivery of 4564015152 CEFEPIME-DEXTROSE 2 GM/50 MLS, a pharmaceutical product, to support military treatment programs and facilities. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp, valued at up to $999,999,999.00 and...
- The Defense Logistics Agency awarded a $1,228.56 delivery order to AmerisourceBergen Drug Corp for Cefazolin 2G/50ML-Dextrose, an antibiotic pharmaceutical product, with performance in Conshohocken, Pennsylvania and an ultimate completion date of July 29, 2025. This firm fixed price delivery order was competitively awarded without set-aside designation and represents a child contract under AmerisourceBergen's larger federal contracting portfolio with the agency. This delivery order derives...
- SPE2DB22D3301Indefinite Delivery Contract
- SPE2DB22D3301-SPE2DB25FY9HFDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,565.69 to AmerisourceBergen Drug Corp for the supply of Cefepime-Dextrose 2 GM/50 mLS, an antibiotic medication commonly used in military and federal healthcare systems. This firm fixed-price delivery order, issued on August 13, 2025, was competitively awarded with no set-aside designation and is scheduled for completion by August 14, 2025. The product will be performed and delivered from AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery order operates under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of pharmaceutical products, medications, vaccines, and medical supplies to support military healthcare programs worldwide. AmerisourceBergen's consistent receipt of competitive awards across diverse pharmaceutical commodities demonstrates the company's established capability to meet federal medical procurement requirements and support the Defense Health Agency and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.6k | 8/13/25 |